GlassScriptPhysician profile
Corey Edward Greene
NPI 1174828867
$2,175.33
in general payments reported to CMS, 2019-2025
17 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $171 · 2023: $482 · 2024: $770 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.58 | 2021-2025 | |
| Janssen Biotech, INC. | $378.71 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $272.76 | 2021-2023 | Ilumya |
| Lilly USA, LLC | $207.86 | 2021-2024 | Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $193.94 | 2023-2025 | Sotyktu, Sprycel |
| Organogenesis INC. | $165.82 | 2024-2025 | Puraply Wound Matrix, Puraply Am, Simplimax |
| Ceribell, INC. | $129.20 | 2024 | Pocket Eeg Device |
| Ucb, INC. | $74.45 | 2025 | Bimzelx |
| Sanofi-Aventis U.S. LLC | $64.95 | 2021 | |
| Pfizer INC. | $56.13 | 2021-2023 | |
| Convatec INC. | $48.79 | 2024-2025 | |
| Incyte Corporation | $46.80 | 2024-2025 | Opzelura |
| Galderma Laboratories, L.P. | $46.35 | 2025 | Nemluvio |
| Novartis Pharmaceuticals Corporation | $38.29 | 2023-2024 | |
| Dermavant Sciences, INC. | $35.77 | 2023-2024 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17.22 | 2021 | |
| Arcutis Biotherapeutics, INC. | $14.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.